Literature DB >> 4572067

Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease.

A A Raubitschek, A S Levin, D P Stites, E B Shaw, H H Fudenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4572067

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  6 in total

1.  Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.

Authors:  Marife Martinez; Vicky Chen; Ann-Jay Tong; Kelsey Hamilton; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

2.  Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis.

Authors:  R D Diamond; R Krzesicki; B Epstein; W Jao
Journal:  Am J Pathol       Date:  1978-05       Impact factor: 4.307

3.  Gastrointestinal complications of congenital immunodeficiency states. The surgeon's role.

Authors:  M W Mulholland; J P Delaney; J E Foker; A S Leonard; R L Simmons
Journal:  Ann Surg       Date:  1983-12       Impact factor: 12.969

4.  Defective Aspergillus killing by neutrophil leucocytes in a case of systemic aspergillosis.

Authors:  A Pagani; R Spalla; F A Ferrari; M Duse; L Lenzi; U Bretz; M Baggiolini; A G Siccardi
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  Disseminated aspergillosis treated with amphotericin B and surgery in a boy with chronic granulomatous disease.

Authors:  B Elgefors; S Haugstvedt; J E Brorsson; E Esbjörner
Journal:  Infection       Date:  1980       Impact factor: 3.553

Review 6.  Immunodiagnosis of aspergillosis.

Authors:  V P Kurup; A Kumar
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.